Expansion Therapeutics is a drug discovery and development company pursuing the vast potential of small molecule medicines for RNA-mediated diseases. Expansion has assembled the intellectual property, know-how, and proprietary enabling technologies and tools necessary to facilitate the creation of potent and specific small molecule binders of RNA. Through this unique platform, Expansion is building a portfolio of novel RNA-targeted drug candidates with activity across a broad number of disease indications. The company’s initial development focus is on therapies for patients with expansion repeat diseases who currently have limited and unsatisfactory treatment options. Expansion is based in San Diego, California and Jupiter, Florida.

Biotechnology

Expansion Therapeutics

Renato Skerlj

Jack Salvucci

Sandra Mueller

Van Ha

Kamalakannan Vishnu

Michelle Arsenault

Sai Velagadupi

Virginia Smith

Helen Crehan

Daniela Saldias

Shrikant Sharma

Jared Baisden

Jason Ilardo

Kamal Vishnu

Toni-Ann Martorano

Jennifer Todesca

Jennifer Visco

Suzanne Rzuczek

Tiviane Vu

Peter Connolly

Andrew Good

Mark Ledeboer

Valerie Cullen

The leadership team at Expansion Therapeutics has a long history of experience in the field of medicinal chemistry and pharmacy. They have worked extensively with various pharmaceutical companies, and have been involved in many research projects at Rutgers University.

Leadership Team

Board of Directors

Leadership Team

About

Team members

Other teams at Expansion Therapeutics

Board of Directors